Isoform 6 of Calpastatin

Calpastatin is an endogenous inhibitor of calpain proteases, which are calcium-activated cysteine proteases involved in protein degradation and cell signaling (UniProt: P20810-6). The protein functions as a regulator of intracellular proteolysis and is expressed across multiple tissues. Calpastatin exists in multiple isoforms, with Isoform 6 being a 791-amino-acid variant.

Dysregulation of calpain-calpastatin signaling has been implicated in neurodegenerative pathways, as uncontrolled calpain activity can contribute to cytoskeletal disruption and neuronal damage. The calpain system is particularly relevant to conditions involving calcium homeostasis imbalance and proteolytic stress.

In Alzheimer's Disease, Isoform 6 of calpastatin is upregulated in post-mortem human AD brain tissue relative to age-matched controls (Chaparral AD proteomics). The protein showed a mean log2 fold-change of +0.72 in a TMT-labeled quantitative proteomics study across four subcellular fractions (P2, P3, S2, S3). This upregulation may reflect compensatory activation of the calpastatin inhibitory pathway in response to elevated calpain activity observed in AD neurodegeneration.